Monday, April 20, 2026
wellness India Expo
Home Tags India

Tag: India

Paras Health reports increment in total number of newly diagnosed pulmonary...

According to the latest data, India’s National TB Elimination Program (NTEP) recorded 26.07 lakh TB cases in 2024—the highest ever reported

World TB Day 2025 Summit: JP Nadda reiterates govt’s commitment to...

Under the 100-day TB Mukt Bharat Abhiyaan, 12.97 crore people were screened for TB with over 7.19 lakh TB patients notified across India

NHAI and Amrita Hospital sign MoU to train first responders in...

Over 150 ambulance workers received hands-on training at Amrita Hospital, Faridabad

CGIAR and ICRISAT drive gender equality in a unique training program

Participants engaged in field visits to Aurepalle Village to learn from self-help groups and women entrepreneurs at the Agri-Ghar facility.

Bharat Biotech enters gene & cell therapies segment, launches India’s only...

The 50,000-square-foot dedicated state-of-the-art CGT facility represents the next milestone in BBIL’s long-standing mission to deliver targeted, life-saving treatments

Genome India Project: Proposals underway to do translational research on available...

The Union Minister of State for Science and Technology, Dr Jitendra Singh informed that DBT has planned to fund translational research in which this dataset will serve as a template, thus maximizing the benefits of the data generated

India Biotech Outlook 2025: The India Advantage at BIO Boston 2025

BioVoice News and the International Contract Pharma Association (ICPA) have collaborated to present an exclusive publication that will highlight India’s leadership in biotech and provide a powerful platform for companies to maximize their presence

Metropolis Foundation empowers 353 medical students with scholarships & research grants

Research grant applications doubled from 29 to 63, reflecting growing student interest in research

EyeQ expands its business in Gujarat, upgrades its Surat facility

Theatre (OTs) dedicated to Cataract, LASIK, and Retina treatments added to meet the growing demand

Syngene acquires its first manufacturing facility in the US

Biologics drug substance facility in Baltimore expected to enhance global innovator flexibility